Sunnybrook Health Sciences Centre

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1948-01-01

Employees: 10K

Market Cap: -

Website: http://www.sunnybrook.ca

Clinical Trials

Metabolic Imaging of the Heart Using Hyperpolarized (13C) Pyruvate Injection

Phase 1

Recruiting

Conditions: Hypertension
Hypertrophy

Interventions: Drug: Hyperpolarized (13) Pyruvate Injection
Drug: Gadolinium

First Posted Date: 2016-01-06

Last Posted Date: 2024-04-22

Lead Sponsor: Sunnybrook Health Sciences Centre

Target Recruit Count: 112

Registration Number: NCT02648009

Locations: 🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
🇨🇦
St. Michael's Hospital, Toronto, Ontario, Canada

Multiparametric MRI for Prostate Cancer Localization and Characterization Using Hyperpolarized Pyruvate (13C) Injection

Phase 1

Withdrawn

Conditions: Prostatic Neoplasms

Interventions: Drug: Hyperpolarized Pyruvate (13C) Injection

First Posted Date: 2016-01-06

Last Posted Date: 2020-01-22

Lead Sponsor: Sunnybrook Health Sciences Centre

Registration Number: NCT02647983

Locations: 🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Analgesic Duration of Long Acting Local Anesthetics for Low Volume Ultrasound-guided Interscalene Brachial Plexus Block

Not Applicable

Completed

Conditions: Brachial Plexus Block
Anesthetics, Local

Interventions: Drug: Ropivacaine 0.5%
Drug: Ropivacaine 1%

First Posted Date: 2015-12-31

Last Posted Date: 2019-07-10

Lead Sponsor: Sunnybrook Health Sciences Centre

Target Recruit Count: 60

Registration Number: NCT02643563

Locations: 🇨🇦
Holland Orthopedic and Arthritic Centre, Toronto, Ontario, Canada

MRI Assisted Focal Boost With HDR Monotherapy for Prostate Cancer Patients

Not Applicable

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Radiation: MRI assisted focal boost with HDR monotherapy

First Posted Date: 2015-12-08

Last Posted Date: 2022-06-14

Lead Sponsor: Sunnybrook Health Sciences Centre

Target Recruit Count: 60

Registration Number: NCT02623933

Locations: 🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Tomosynthesis Mammographic Imaging Screening Trial

Not Applicable

Active, not recruiting

Conditions: Breast Cancer

Interventions: Device: Tomosynthesis

First Posted Date: 2015-11-27

Last Posted Date: 2024-04-18

Lead Sponsor: Sunnybrook Health Sciences Centre

Target Recruit Count: 3065

Registration Number: NCT02616432

Locations: 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada
🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
🇨🇦
X-Ray 505 (Under the BCCA Screening Mammography Program of BC), Vancouver, British Columbia, Canada

and more 1 locations

A Proof of Principle Study of Pembrolizumab With SBRT in TKI mRCC Patients

Phase 2

Completed

Conditions: Stage IV Renal Cell Cancer AJCC V7

Interventions: Drug: Pembrolizumab
Radiation: Stereotactic Body Radiation Therapy

First Posted Date: 2015-11-09

Last Posted Date: 2021-09-01

Lead Sponsor: Sunnybrook Health Sciences Centre

Target Recruit Count: 4

Registration Number: NCT02599779

Locations: 🇨🇦
Princess Margaret Hospital, Toronto, Ontario, Canada
🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
🇨🇦
Tom Baker Cancer Centre, Calgary, Alberta, Canada

Building Capacity in the System to Support Persons With Stroke and Cognitive Impairment

Completed

Conditions: Stroke

Interventions: Behavioral: CO-OP KT Exposure

First Posted Date: 2015-11-05

Last Posted Date: 2018-09-20

Lead Sponsor: Sunnybrook Health Sciences Centre

Target Recruit Count: 24

Registration Number: NCT02597569

Locations: 🇨🇦
Providence Healthcare, Toronto, Ontario, Canada
🇨🇦
Bridgepoint Active Healthcare, Toronto, Ontario, Canada
🇨🇦
Sunnybrook Health Sciences Centre - St. John's Rehab, Toronto, Ontario, Canada

and more 2 locations

A Trial of an Audit and Feedback Report to Improve Colonoscopy Performance

Not Applicable

Completed

Conditions: Colorectal Polyps

Interventions: Other: A/F report plus a high intensity intervention
Other: Individualized A/F report
Other: A/F report plus a low intensity intervention
Other: A/F report alone

First Posted Date: 2015-11-03

Last Posted Date: 2018-09-07

Lead Sponsor: Sunnybrook Health Sciences Centre

Target Recruit Count: 833

Registration Number: NCT02595775

Effect of Ketamine vs. Active Placebo on Suicidal Ideation in Depressed Inpatients With Major Depressive Disorder or Bipolar Depression.

Early Phase 1

Completed

Conditions: Bipolar II Disorder
Bipolar Depression
Suicidal Ideation
Major Depressive Disorder
Bipolar I Disorder

Interventions: Drug: Midazolam
Drug: Ketamine
Other: Treatment as usual (TAU)

First Posted Date: 2015-11-01

Last Posted Date: 2017-07-26

Lead Sponsor: Sunnybrook Health Sciences Centre

Target Recruit Count: 9

Registration Number: NCT02593643

Locations: 🇨🇦
Sunnybook Health Sciences Centre, Toronto, Ontario, Canada

Stereotactic Radiotherapy for Oligometastatic Prostate Cancer

Phase 1

Conditions: Prostatic Neoplasms

Interventions: Radiation: stereotactic radiotherapy

First Posted Date: 2015-09-30

Last Posted Date: 2022-03-08

Lead Sponsor: Sunnybrook Health Sciences Centre

Target Recruit Count: 90

Registration Number: NCT02563691

Locations: 🇨🇦
Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy